Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cells ; 10(9)2021 08 28.
Artigo em Inglês | MEDLINE | ID: mdl-34571877

RESUMO

Glucocorticoids are the most powerful anti-inflammatory and immunosuppressive pharmacological drugs available, despite their adverse effects. Glucocorticoid-induced leucine zipper (GILZ) is a glucocorticoid-induced gene that shares several anti-inflammatory properties with glucocorticoids. Although immunosuppressive effects of glucocorticoids on neutrophils remain poorly understood, we previously demonstrated that GILZ suppresses neutrophil activation under glucocorticoid treatment. Here, we sought to explore the regulation of Toll-like receptor 2 (TLR2) by the synthetic glucocorticoid dexamethasone (DEX) on neutrophils and the associated GILZ involvement. Peripheral blood neutrophils were isolated from wild type and GILZ-knock-out (KO) mice. TLR2 was found to be downregulated by the in vivo administration of glucocorticoids in wild type but not in GILZ-KO neutrophils, suggesting the involvement of GILZ in TLR2 downregulation. Accordingly, the TLR2-associated anti-fungal activity of neutrophils was reduced by DEX treatment in wild type but not GILZ-KO neutrophils. Furthermore, GILZ did not interact with NF-κB but was found to bind with STAT5, a pivotal factor in the regulation of TLR2 expression. A similar modulation of TLR2 expression, impaired phagocytosis, and killing activity was observed in circulating human neutrophils treated in vitro with DEX. These results demonstrate that glucocorticoids reduce the ability of neutrophils to respond to infections by downregulating TLR2 via GILZ, thereby reducing critical functions.


Assuntos
Dexametasona/farmacologia , Regulação para Baixo/efeitos dos fármacos , Neutrófilos/imunologia , Receptor 2 Toll-Like/metabolismo , Fatores de Transcrição/genética , Animais , Dexametasona/administração & dosagem , Glucocorticoides/farmacologia , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Neutrófilos/citologia , Neutrófilos/metabolismo , Fator de Transcrição STAT5/metabolismo , Fatores de Transcrição/deficiência , Fatores de Transcrição/metabolismo , Regulação para Cima/efeitos dos fármacos
2.
Viruses ; 13(3)2021 03 05.
Artigo em Inglês | MEDLINE | ID: mdl-33807521

RESUMO

The aim of this study was to establish the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on inanimate surfaces such as plastic, stainless steel, and glass during UV-C irradiation which is a physical means commonly utilized in sanitization procedures. The viral inactivation rate, virus half-life, and percentage of titer reduction after UV-C irradiation were assessed. Infectivity was maintained on plastic and glass until 120 h and on stainless steel until 72 h. The virus half-life was 5.3, 4.4, and 4.2 h on plastic, stainless steel, and glass, respectively. In all cases, titer decay was >99% after drop drying. UV-C irradiation efficiently reduced virus titer (99.99%), with doses ranging from 10.25 to 23.71 mJ/cm2. Plastic and stainless steel needed higher doses to achieve target reduction. The total inactivation of SARS-CoV-2 on glass was obtained with the lower dose applied. SARS-CoV-2 survival can be long lasting on inanimate surfaces. It is worth recommending efficient disinfection protocols as a measure of prevention of viral spread. UV-C can provide rapid, efficient and sustainable sanitization procedures of different materials and surfaces. The dosages and mode of irradiation are important parameters to consider in their implementation as an important means to fight the SARS-CoV-2 pandemic.


Assuntos
COVID-19/virologia , Desinfecção/métodos , SARS-CoV-2/efeitos da radiação , Inativação de Vírus/efeitos da radiação , COVID-19/prevenção & controle , Desinfecção/instrumentação , Vidro/análise , Humanos , SARS-CoV-2/genética , SARS-CoV-2/fisiologia , Aço Inoxidável/análise , Raios Ultravioleta , Carga Viral/efeitos da radiação
3.
Sci Rep ; 10(1): 1978, 2020 02 06.
Artigo em Inglês | MEDLINE | ID: mdl-32029862

RESUMO

Bacterial vaginosis (BV) is one of the most common vaginal infections among women of childbearing age. Gardnerella vaginalis (G. vaginalis) is a keystone microorganism present in more than 95% of all BV cases. The first step of the infection process in BV is mediated by interaction of microorganisms with epithelial cells (ECs). However, the role of these cells in BV pathogenesis is largely unknown. The present study aimed to investigate the vaginal EC response during BV. Twenty healthy women and 34 women with BV were enrolled in this study. The number of ECs in the vaginal swab was counted and analyzed for intracellular signals and apoptosis by flow cytometry. Cell damage was evaluated by lactate dehydrogenase assay. Compared to that in healthy donors, the percentage of exfoliated vaginal ECs was increased in women with BV, and an absence of neutrophils was observed in both groups. Activation signals, such as p-IκBα and c-Fos were unmodulated in the vaginal ECs of women with BV. Moreover, EC damage and apoptosis were significantly increased in patients with BV. Apoptosis was related to caspase-3 activation and the presence of G. vaginalis. This study provides the first evidence of a direct involvement of G. vaginalis in the apoptotic process of vaginal ECs during BV. This effect was mediated by caspase-3 activation, and G. vaginalis appeared to be one of causes for inducing EC apoptosis in BV. Hence, our findings suggest a possible explanation for the increased exfoliation of ECs in the vagina during BV.


Assuntos
Apoptose/imunologia , Células Epiteliais/patologia , Gardnerella vaginalis/imunologia , Vagina/patologia , Vaginose Bacteriana/imunologia , Adulto , Estudos de Casos e Controles , Células Epiteliais/imunologia , Células Epiteliais/microbiologia , Feminino , Gardnerella vaginalis/isolamento & purificação , Voluntários Saudáveis , Humanos , Pessoa de Meia-Idade , Vagina/citologia , Vagina/imunologia , Vagina/microbiologia , Vaginose Bacteriana/diagnóstico , Vaginose Bacteriana/microbiologia , Vaginose Bacteriana/patologia , Adulto Jovem
4.
J Infect Dis ; 220(10): 1645-1654, 2019 10 08.
Artigo em Inglês | MEDLINE | ID: mdl-31300818

RESUMO

BACKGROUND: Vaginal candidiasis is common disease affecting women; however, how Candida albicans shift from commensalism towards a pathogenic status remains poorly understood. The present study investigated the vaginal epithelial cell (EC) response dynamics under various conditions. METHODS: Healthy women, asymptomatic C. albicans carriers, and symptomatic patients with vaginal candidiasis were enrolled in this study. ECs in vaginal swabs were analyzed with cytofluorimetric analysis for pattern recognition receptors and intracellular signals, with lactate dehydrogenase assay performed for cell damage, and an enzyme-linked immunosorbent assay for cytokine expression. RESULTS: The level of toll-like receptor 4 (TLR4), TLR2, and erythropoietin-producing hepatoma A2 (EphA2) expression was significantly higher in ECs from asymptomatic and symptomatic subjects compared to healthy subjects. Activation of transcription factors, nuclear factor-κB (NF-κB) and c-Fos-p-38, was observed in ECs from symptomatic and asymptomatic pseudohyphae/hyphae carriers but not from the asymptomatic yeast carriers. EC damage was only observed in symptomatic patients. CONCLUSIONS: The presence of pseudohyphae/hyphae is required to determine vaginal candidiasis; however, it may be not sufficient to induce the pathologic process associated with neutrophil recruitment and EC damage. This study sheds light on the ambiguous role of the hyphal form during vaginal human commensalism.


Assuntos
Candida albicans/crescimento & desenvolvimento , Candidíase Vulvovaginal/patologia , Portador Sadio/imunologia , Células Epiteliais/imunologia , Células Epiteliais/microbiologia , Hifas/crescimento & desenvolvimento , Vagina/microbiologia , Adulto , Sobrevivência Celular , Células Epiteliais/fisiologia , Feminino , Humanos , Fatores Imunológicos/análise , Pessoa de Meia-Idade , Adulto Jovem
5.
Mycopathologia ; 175(1-2): 1-11, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23054331

RESUMO

The animal models available for studying the immune response to genital tract infection require induction of a pseudo estrous state, usually achieved by administration of 17-ß-estradiol. In our experimental model of vaginal candidiasis, under pseudo estrus, different strains of mice were used. We observed major differences in the clearance of Candida albicans infection among the different strains, ascribable to differing susceptibility to estradiol treatment. In the early phase of infection CD1, BALB/c, C57BL/6 albino and C57BL/6 mice were colonized to similar levels, while in the late phase of infection, BALB/c mice, which are considered genetically resistant to C. albicans infection, exhibited greater susceptibility to vaginal candidiasis than CD1 and C57BL/6 albino strains of mice. This was because estradiol induced "per se" enlarged and fluid-filled uteri, more pronounced in infected mice and consistently more evident in BALB/c and C57BL/6 mice than in CD1 mice. Unlike CD1, BALB/c and C57BL/6 mice showed a heavy fungal colonization of the uterus, even though C57BL/6 mice apparently cleared C. albicans from the vagina. The presence of C. albicans in the vagina and uterus was accompanied by a heavy bacterial load. Collectively these observations prompted us to carry out a careful analysis of estradiol effects in a mouse model of vaginal infection.


Assuntos
Candida albicans/fisiologia , Candidíase Vulvovaginal/imunologia , Candidíase Vulvovaginal/patologia , Modelos Animais de Doenças , Suscetibilidade a Doenças , Estrogênios/metabolismo , Camundongos , Animais , Candidíase Vulvovaginal/genética , Feminino , Especificidade da Espécie
6.
J Immunol ; 183(1): 191-200, 2009 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-19542430

RESUMO

Rheumatoid arthritis (RA) is a chronic and debilitating autoimmune disease characterized by chronic joint inflammation with subsequent cartilage and bone destruction. RA is emerging as a model of IL-17-driven autoimmune inflammatory disease. IL-17 is a marker for Th17 cells, with its master regulator being the retinoic acid receptor-related orphan receptor (RORgammat) regulated by STAT3 signaling. Glucuronoxylomannan (GXM), a polysaccharide representing the main component of the capsular material of the opportunistic yeast Cryptococcus neoformans, exhibits potent immunosuppressive properties both in vitro and in vivo. The present study investigates the effects of GXM treatment on the progression of collagen-induced arthritis. GXM suppressed clinical signs of collagen-induced arthritis and blocked joint erosion progression. This effect was mediated by down-regulation of key cytokines involved in the pathogenesis of RA such as TNF-alpha and IL-1beta, and up-regulation of the inhibitory cytokine IL-10. Moreover, a reduction of IL-6 and TGF-beta, which inhibit Th17 differentiation with consequent decreased IL-17 production at the local and systemic level, was observed. The effect of GXM on Th17 differentiation mirrored the reduction in STAT3 activation and inhibition of RORgammat synthesis. Consequently, this work highlights the beneficial properties of an efficacious compound that could eventually be destined to the clinic.


Assuntos
Artrite Reumatoide/imunologia , Cryptococcus neoformans/imunologia , Citocinas/biossíntese , Imunossupressores/administração & dosagem , Mediadores da Inflamação/metabolismo , Interleucina-17/fisiologia , Polissacarídeos/administração & dosagem , Linfócitos T Auxiliares-Indutores/imunologia , Animais , Antígenos de Fungos/administração & dosagem , Antígenos de Fungos/imunologia , Artrite Experimental/tratamento farmacológico , Artrite Experimental/epidemiologia , Artrite Experimental/imunologia , Artrite Experimental/patologia , Artrite Reumatoide/tratamento farmacológico , Artrite Reumatoide/patologia , Reabsorção Óssea/imunologia , Reabsorção Óssea/patologia , Colágeno Tipo II/toxicidade , Citocinas/antagonistas & inibidores , Citocinas/fisiologia , Imunossupressores/imunologia , Incidência , Mediadores da Inflamação/antagonistas & inibidores , Mediadores da Inflamação/fisiologia , Interleucina-17/antagonistas & inibidores , Masculino , Camundongos , Camundongos Endogâmicos DBA , Osteoclastos/imunologia , Osteoclastos/patologia , Polissacarídeos/imunologia , Polissacarídeos/uso terapêutico , Ligante RANK/biossíntese , Ligante RANK/genética , Índice de Gravidade de Doença , Linfócitos T Auxiliares-Indutores/metabolismo , Linfócitos T Auxiliares-Indutores/patologia
7.
Cell Microbiol ; 10(10): 2129-37, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18647312

RESUMO

A purified microbial capsular polysaccharide of Cryptococcus neoformans, glucuronoxylomannan (GXM), induces Fas ligand (FasL) upregulation on macrophages and, as a consequence, apoptosis of lymphocytes. The mechanisms that lead to lymphocyte apoptosis in both in vitro and in vivo systems were investigated by cytofluorimetric analysis and Western blotting experiments. Caspase 8 cleaves caspase 3 in two different pathways: directly as well as indirectly by activation of Bcl-2 interacting domain, which initiates caspase 9 cleavage. Therefore, the caspase 8 and caspase 9 pathways cooperate in an amplification loop for efficient cell death, and noteworthily we provide evidence that they are both activated in one single cell. Furthermore, both activation of GXM-mediated caspase 8 and apoptosis were also found in in vivo systems in an experimental model of murine candidiasis. Collectively, our data show that GXM-induced apoptosis involves, in a single cell, a cross-talk between extrinsic and intrinsic pathways. Such a finding offers opportunities for the therapeutic usage of this polysaccharide in appropriate clinical settings for taming T-cell responses.


Assuntos
Apoptose , Cryptococcus neoformans/imunologia , Polissacarídeos/imunologia , Animais , Candidíase/imunologia , Caspase 8/metabolismo , Caspases/metabolismo , Feminino , Humanos , Células Jurkat , Camundongos , Modelos Biológicos , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo
8.
J Immunol ; 177(10): 6842-51, 2006 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-17082598

RESUMO

A microbial polysaccharide (glucuronoxylomannan (GXM)) exerts potent immunosuppression by direct engagement to immunoinhibitory receptor FcgammaRIIB. Activation of FcgammaRIIB by GXM leads to the recruitment and phosphorylation of SHIP that prevents IkappaBalpha activation. The FcgammaRIIB blockade inhibits GXM-induced IL-10 production and induces TNF-alpha secretion. GXM quenches LPS-induced TNF-alpha release via FcgammaRIIB. The addition of mAb to GXM reverses GXM-induced immunosuppression by shifting recognition from FcgammaRIIB to FcgammaRIIA. These findings indicate a novel mechanism by which microbial products can impair immune function through direct stimulation of an inhibitory receptor. Furthermore, our observations provide a new mechanism for the ability of specific Ab to reverse the immune inhibitory effects of certain microbial products.


Assuntos
Anticorpos Monoclonais/metabolismo , Antígenos CD/metabolismo , Imunossupressores/antagonistas & inibidores , Imunossupressores/farmacologia , Polissacarídeos/antagonistas & inibidores , Polissacarídeos/imunologia , Receptores de IgG/metabolismo , Anticorpos Monoclonais/fisiologia , Antígenos CD/fisiologia , Linhagem Celular , Cryptococcus neoformans/imunologia , Humanos , Proteínas I-kappa B/antagonistas & inibidores , Proteínas I-kappa B/metabolismo , Imunossupressores/metabolismo , Inositol Polifosfato 5-Fosfatases , Interleucina-10/antagonistas & inibidores , Interleucina-10/biossíntese , Interleucina-10/metabolismo , Macrófagos/imunologia , Macrófagos/metabolismo , Monócitos/imunologia , Monócitos/metabolismo , Inibidor de NF-kappaB alfa , Monoéster Fosfórico Hidrolases/metabolismo , Fosforilação , Polissacarídeos/metabolismo , Receptores de IgG/fisiologia , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Fator de Necrose Tumoral alfa/biossíntese , Fator de Necrose Tumoral alfa/metabolismo
9.
Med Mycol ; 44(2): 119-26, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16519014

RESUMO

A previous paper demonstrated that indinavir affects the virulence of Cryptococcus neoformans, thereby rendering the fungus more susceptible to killing by natural effector cells. This study demonstrates that inoculation of immunosuppressed mice with C. neoformans previously exposed to indinavir, in comparison to untreated C. neoformans, results in: (i) a more pronounced secretion of interleukin-12 by splenic dendritic cells; (ii) reduction of CD14 and Fc gammaRs expression on splenic dendritic cells, and upregulation of CD86 and CD40 molecules; (iii) enhancement of interferon-y and interleukin-2 production by splenic T cells and increase of their proliferation in response to fungal antigens; and (iv) survival from an otherwise lethal challenge, correlated with a drastic decrease in colony forming units from brain and liver. In conclusion, these data indicate that indinavir interaction with C. neoformans could be beneficial because of its direct influence on fungal virulence and blunting of the deleterious effects exerted by C. neoformans on host immune response. Thus, indinavir could be crucial in addressing the outcome of cryptococcosis in immunocompromised hosts.


Assuntos
Criptococose/imunologia , Cryptococcus neoformans/efeitos dos fármacos , Cryptococcus neoformans/imunologia , Inibidores da Protease de HIV/farmacologia , Indinavir/farmacologia , Animais , Antígeno B7-2/imunologia , Linfócitos T CD4-Positivos/citologia , Linfócitos T CD4-Positivos/imunologia , Antígenos CD40/imunologia , Criptococose/tratamento farmacológico , Criptococose/microbiologia , Cryptococcus neoformans/patogenicidade , Células Dendríticas/citologia , Células Dendríticas/imunologia , Células Dendríticas/metabolismo , Feminino , Hospedeiro Imunocomprometido , Interferon gama/biossíntese , Interferon gama/imunologia , Interleucina-12/imunologia , Interleucina-12/metabolismo , Interleucina-2/biossíntese , Interleucina-2/imunologia , Receptores de Lipopolissacarídeos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Óxido Nítrico/imunologia , Receptores de IgG/imunologia
10.
J Immunol ; 174(6): 3461-8, 2005 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-15749881

RESUMO

The major component of capsular material of Cryptococcus neoformans is glucuronoxylomannnan (GXM), a polysaccharide that exhibits potent immunosuppressive properties in vitro and in vivo. The results reported here show that 1) soluble purified GXM induces a prompt, long-lasting, and potent up-regulation of Fas ligand (FasL) on macrophages, 2) the up-regulation of FasL is related to induced synthesis and increased mobilization to the cellular surface, 3) this effect is largely mediated by interaction between GXM and TLR4, 4) FasL up-regulation occurs exclusively in GXM-loaded macrophages, 5) macrophages that show up-regulation of FasL induce apoptosis of activated T cells expressing Fas and Jurkat cells that constitutively express Fas, and 6) anti-Fas Abs rescue T cells from apoptosis induced by GXM. Collectively our results reveal novel aspects of the immunoregulatory properties of GXM and suggest that this nontoxic soluble compound could be used to dampen the immune response, to promote or accelerate the death receptor, and to fix FasL expression in a TLR/ligand-dependent manner. In the present study, we delineate potential new therapeutic applications for GXM that exploit death receptors as key molecular targets in regulating cell-mediated cytotoxicity, immune homeostasis, and the immunopathology of diseases.


Assuntos
Cryptococcus neoformans/imunologia , Macrófagos/imunologia , Glicoproteínas de Membrana/biossíntese , Polissacarídeos/imunologia , Apoptose , Cicloeximida/farmacologia , Dactinomicina/farmacologia , Proteína Ligante Fas , Humanos , Tolerância Imunológica , Fatores Imunológicos/farmacologia , Técnicas In Vitro , Células Jurkat , Ativação Linfocitária , Macrófagos/efeitos dos fármacos , Glicoproteínas de Membrana/metabolismo , Polissacarídeos/farmacologia , Receptores de Superfície Celular/metabolismo , Linfócitos T/citologia , Linfócitos T/imunologia , Receptor 4 Toll-Like , Receptores Toll-Like
11.
J Infect Dis ; 191(1): 127-37, 2005 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-15593014

RESUMO

Glucuronoxylomannan (GXM) is a microbial compound that can modulate the immune response. We investigated (1) the receptors involved in uptake of GXM on monocyte-derived macrophages (MDMs) from healthy donors, (2) the effects of GXM on expression of specific receptors, (3) the effects of GXM mediated by pattern-recognition receptors, and (4) GXM modulation of MDM accessory and secretory functions. Cellular receptors involved in uptake of GXM included Fc gamma RII, CD18, Toll-like receptor (TLR) 4, and CD14. Some biological functions of MDMs were profoundly affected by treatment with GXM, resulting in (1) increased expression of CD40 and CD86 via perturbation of TLR4, (2) decreased expression of major histocompatibility complex class II, (3) induction of interleukin-10 but not of tumor necrosis factor-alpha, and (4) decreased lipopolysaccharide (LPS)-induced production of cytokines. GXM represents an attractive compound to limit inflammatory processes and induce an LPS-tolerant state.


Assuntos
Antígenos CD/análise , Citocinas/biossíntese , Regulação da Expressão Gênica , Macrófagos/imunologia , Polissacarídeos/imunologia , Antígeno B7-2 , Antígenos CD40/análise , Antígenos de Histocompatibilidade Classe II/análise , Humanos , Proteínas I-kappa B/análise , Fatores Imunológicos/imunologia , Fatores Imunológicos/farmacologia , Glicoproteínas de Membrana/análise , Glicoproteínas de Membrana/metabolismo , Inibidor de NF-kappaB alfa , NF-kappa B/análise , Polissacarídeos/farmacologia , Receptores de Superfície Celular/metabolismo , Receptores Imunológicos/análise , Receptor 4 Toll-Like , Receptores Toll-Like , Fator de Necrose Tumoral alfa/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA